BeStock  

Medpace MEDP

US equityMarket cap rank #1009Diagnostics & Research
$610.54 −$23.44 (-3.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $605.49 -0.83%
Open$632.09
Prev close$633.98
Day range$606.73 – $633.87
Volume236.8K
Market cap$17.08B
P/E (TTM)33.9
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$716.00M+8.5% YoY
Operating profit$165.54M+16.7% YoY
Net profit$137.46M+23.7% YoY
Diluted EPS$4.84+25.4% YoY
Free cash flow$196.44M-16.6% YoY
Operating cash flow$216.60M

Revenue, last 8 quarters

$536.6MDec '24$558.6MMar '25$603.3MJun '25$659.9MSep '25$708.5MDec '25$706.6MMar '26$707.3MJun '26$716.0MSep '26

Net profit, last 8 quarters

$117.0MDec '24$114.6MMar '25$90.3MJun '25$111.1MSep '25$135.1MDec '25$123.9MMar '26$121.4MJun '26$137.5MSep '26

Diluted EPS by quarter

3.67Dec '243.67Mar '253.10Jun '253.86Sep '254.67Dec '254.28Mar '264.25Jun '264.84Sep '26

Free cash flow by quarter

$183.0MDec '24$115.8MMar '25$142.4MJun '25$235.5MSep '25$188.1MDec '25$145.0MMar '26$138.1MJun '26$196.4MSep '26

Annual revenue

$925.9MFY20$1.1BFY21$1.5BFY22$1.9BFY23$2.1BFY24$2.5BFY25

Profitability & balance sheet

Gross margin29.1%
Operating margin21.4%
Net margin18.2%
Return on equity117.9%
Return on assets25.5%
Return on invested capital90.6%
Current ratio0.83
Liabilities / assets74.6%
Cash & investments$705.32M
Total debt$146.04M
Net cash (debt)$559.27M
Free cash flow / sales23.5%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $716.00M $707.33M $706.60M $2.53B $708.45M
Total Operating Revenue $716.00M $707.33M $706.60M $2.53B $708.45M
Cost of Revenue $492.12M $505.69M $510.28M $1.77B $503.13M
Gross Profit $223.89M $201.64M $196.33M $760.62M $205.32M
Operating Expense $58.35M $54.81M $54.82M $225.68M $52.05M
Selling and Admin Expenses $51.77M $48.10M $47.92M $197.56M $44.92M
Depreciation & Amortization & Depletion $6.58M $6.71M $6.91M $28.12M $7.13M
-Depreciation & Amortization $6.58M $6.71M $6.91M $28.12M $7.13M
Operating Profit $165.54M $146.82M $141.50M $534.94M $153.27M
Net Non-Operating Interest Income (Expense) $5.35M $4.99M $5.12M $12.78M $3.72M
Total Other Finance Costs -$5.35M -$4.99M -$5.12M -$12.78M -$3.72M
Other Income (Expense) $17,000.00 -$147,000.00 $971,000.00 -$5.34M -$158,000.00
Other Non-Operating Income (Expenses) $17,000.00 -$147,000.00 $971,000.00 $2.39M $7.57M
Pretax Profit $170.91M $151.66M $147.59M $542.38M $156.83M
Tax $33.45M $30.30M $23.72M $91.25M $21.70M
Net Profit $137.46M $121.36M $123.87M $451.12M $135.13M
Profit from Continuing Operations $137.46M $121.36M $123.87M $451.12M $135.13M
Net Income to Parent Company $137.46M $121.36M $123.87M $451.12M $135.13M
Other Preferred Stock Dividends $0.00 – – $0.00 $0.00
Net Income to Common Stockholders $137.46M $121.36M $123.87M $451.12M $135.13M
Basic EPS $4.92 $4.31 $4.35 $15.64 $4.78
Diluted EPS $4.84 $4.25 $4.28 $15.28 $4.67
Gain on Sale of Security – – – -$7.73M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $2.30B $2.06B $2.13B $1.98B $1.98B
Total Current Assets $1.25B $1.05B $1.14B $989.62M $989.62M
Cash and Cash Equivalents & Short-Term Investments $705.32M $502.69M $652.68M $497.05M $497.05M
-Cash and Cash Equivalents $705.32M $502.69M $652.68M $497.05M $497.05M
Receivables $447.64M $441.80M $394.58M $402.08M $402.08M
-Accounts Receivable $419.84M $420.56M $370.41M $376.76M $376.76M
-Other Receivables $27.83M $21.27M $24.20M $25.35M $25.35M
-Receivables Adjustments Allowances -$28,000.00 -$28,000.00 -$28,000.00 -$29,000.00 -$29,000.00
Other Current Assets $92.04M $105.80M $91.79M $90.50M $90.50M
Total Non-Current Assets $1.06B $1.01B $990.56M $985.85M $985.85M
Net PPE $327.55M $282.96M $263.36M $248.87M $248.87M
-Gross PPE $327.55M $282.96M $263.36M $372.14M $372.14M
Goodwill and Other Intangible Assets $695.35M $695.51M $695.66M $695.82M $695.82M
-Goodwill $662.40M $662.40M $662.40M $662.40M $662.40M
-Other Intangible Assets $32.96M $33.11M $33.27M $33.42M $33.42M
Non-Current Deferred Assets $3.27M $3.23M $3.22M $19.22M $19.22M
Other Non-Current Assets $31.42M $25.20M $28.32M $21.94M $21.94M
Total Liabilities $1.72B $1.62B $1.53B $1.52B $1.52B
Total Current Liabilities $1.50B $1.44B $1.35B $1.34B $1.34B
Payables $43.68M $37.53M $34.43M $28.14M $28.14M
-Accounts Payable $43.68M $37.53M $34.43M $28.14M $28.14M
Current Accrued Expenses $344.86M $371.65M $344.46M $328.24M $328.24M
Current Deferred Liabilities $961.86M $904.72M $856.34M $854.39M $854.39M
Other Current Liabilities $47.23M $42.10M $48.18M $52.83M $52.83M
Total Non-Current Liabilities $221.56M $187.89M $186.29M $172.65M $172.65M
Long Term Debt and Capital Lease Obligation $146.04M $120.10M $122.26M $113.64M $113.64M
-Long Term Capital Lease Obligation $146.04M $120.10M $122.26M $113.64M $113.64M
Non-Current Deferred Liabilities $13.66M $8.21M $3.93M $1.36M $1.36M
Other Non-Current Liabilities $61.86M $59.58M $60.10M $57.66M $57.66M
Total Equity $584.94M $433.86M $598.31M $459.07M $459.07M
Stockholders' Equity $584.94M $433.86M $598.31M $459.07M $459.07M
Capital Stock $280,000.00 $279,000.00 $286,000.00 $284,000.00 $284,000.00
-Common Stock $280,000.00 $279,000.00 $286,000.00 $284,000.00 $284,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $978.28M $964.18M $953.42M $935.83M $935.83M
Retained Earnings -$373.57M -$511.37M -$336.11M -$459.98M -$459.98M
Less: Treasury Stock -$12.15M -$12.15M -$12.16M -$12.16M -$12.16M
Gains/Losses Not Affecting Retained Earnings -$7.90M -$7.08M -$7.12M -$4.91M -$4.91M
-Accumulated Depreciation – – – -$123.27M -$123.27M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $216.60M $162.01M $151.79M $713.22M $192.65M
Net cash flow from continuing operations $216.60M $162.01M $151.79M $713.22M $192.65M
Net Income from Continuing Operations $137.46M $121.36M $123.87M $451.12M $135.13M
Depreciation & Depletion & Amortization $6.58M $6.71M $6.91M $28.12M $7.13M
Deferred Tax $5.40M $4.28M $18.54M $80.77M $17.41M
Other Non-Cash Items $6.58M $5.91M $6.25M $22.14M $5.24M
Change in Working Capital $52.98M $19.40M -$8.70M $96.28M $22.12M
-Change in Receivables -$5.79M -$47.18M $7.82M -$106.22M -$29.10M
-Change in Prepaid Assets $13.37M -$14.15M -$1.80M -$27.10M -$11.49M
-Change in Payables and Accrued Expense -$6.10M $44.89M -$1.22M $99.71M $40.90M
-Change in Other Current Liabilities -$5.45M -$7.06M -$5.29M -$25.16M -$7.03M
-Change In Other Working Capital $56.95M $42.91M -$8.22M $155.04M $28.84M
Net cash flow from investing -$20.14M -$23.89M -$6.75M -$31.14M -$4.47M
Net Cash Flow from Continuing Investing Activities -$20.14M -$23.89M -$6.75M -$31.14M -$4.47M
Net Other Investing Changes $23,000.00 $26,000.00 $66,000.00 $216,000.00 $63,000.00
Financing Cash Flow $6.50M -$288.34M $12.67M -$860.39M $22.73M
Net Cash Flow from Continuing Financing Activities $6.50M -$288.34M $12.67M -$860.39M $22.73M
Net Common Stock Issuance $0.00 -$294.76M $0.00 -$917.39M $0.00
Proceeds from Stock Option Exercised $6.50M $6.42M $12.67M $57.00M $22.73M
Ending Cash Balance $705.32M $502.69M $652.68M $497.05M $497.05M
Net Change in Cash $202.96M -$150.21M $157.71M -$178.31M $210.91M
Beginning Cash Balance $502.69M $652.68M $497.05M $669.44M $285.35M
Effect of Exchange Rate Changes -$328,000.00 $221,000.00 -$2.08M $5.92M $790,000.00
Free Cash Flow $196.44M $138.10M $144.97M $681.87M $188.12M
Capital Expenditure – -$23.91M -$6.81M – –
Net PPE Purchase and Sale – – – -$31.36M -$4.54M
Net Issuance Payments Of Debt – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on MEDP.

Sign in to join the discussion.

Scroll to Top